From the blog

What the GLP-1 Drugs Take From Your Muscle

Quick answers

How much of the weight lost on GLP-1 drugs is muscle?
In a network meta-analysis of 22 randomized trials, lean mass loss made up roughly 25% of total weight lost, averaging about 0.86 kg [1]. A separate review of the more potent agents put the figure nearer 10% of the lean mass people started with, or around 6 kg [2].
Are all GLP-1 drugs the same for muscle?
No. Tirzepatide and semaglutide produced the greatest weight and fat loss but were among the least effective at preserving lean mass. Liraglutide was the only agent in that analysis to reduce weight significantly without a significant reduction in lean mass [1].
What protects muscle during weight loss?
Resistance training has the strongest evidence. Supervised programs lasting more than ten weeks have produced increases of roughly 3 kg in lean mass and about 25% in strength [2].

About a quarter of the weight lost on a GLP-1 drug is not fat. In a network meta-analysis of twenty-two randomized controlled trials covering 2,258 participants, the drugs reduced total body weight by an average of 3.55 kg, fat mass by 2.95 kg and lean mass by 0.86 kg, which is roughly twenty-five percent of the total lost [1]. A review of the more potent agents put it higher, at around ten percent of the lean mass people started with, roughly six kilograms, and described that as comparable to a decade or more of aging [2]. Resistance training is what protects it: supervised programs running longer than ten weeks have produced increases of roughly three kilograms in lean mass and about twenty-five percent in strength [2].

The fair thing next, because I am not here to frighten anyone off a medication that is helping them.

These drugs work. In trials, the newer agents produce weight loss of fifteen to twenty-four percent of body weight, along with better blood pressure, cholesterol, blood glucose and insulin [2]. For some women those are changes that years of effort did not deliver, and I am not going to pretend otherwise.

What gets much less airtime is what happens to your muscle while it is happening.

How much of GLP-1 weight loss is muscle?

A network meta-analysis in Metabolism pooled twenty-two randomized controlled trials covering 2,258 participants, looking at what happened to fat mass and lean mass rather than just total weight [1].

The GLP-1 drugs reduced total body weight by an average of 3.55 kg, fat mass by 2.95 kg, and lean mass by 0.86 kg. Lean mass loss accounted for roughly twenty-five percent of the total weight lost [1].

A review in Diabetes Care looking at the more potent agents put it higher, at around ten percent of the lean mass people started with, or roughly six kilograms. The authors described that as comparable to a decade or more of aging [2].

I sat with that sentence for a while. A decade of aging, in a matter of months.

The counterpoint, which is real

There is a finding in that network meta-analysis that cuts the other way, and leaving it out would be dishonest, because showing the untidy version of a finding is the standard this site runs on.

While absolute lean mass fell, relative lean mass, meaning the percentage change from each person's own starting lean mass, was not significantly affected [1]. Researchers who read that as ordinary physiology rather than drug-specific harm have a point worth taking seriously.

Here is where I come down. Proportional is reassuring if you had plenty of muscle to start with. It is much less reassuring if you are a woman in your fifties who was already losing muscle to age, who has never trained with resistance, and for whom six kilograms is coming off a reserve that was thin to begin with.

Proportions do not carry your shopping. Muscle does.

Are all the GLP-1 drugs the same for muscle?

The most practically useful finding in that whole analysis was that the drugs are not interchangeable.

Tirzepatide at 15 mg weekly and semaglutide at 2.4 mg weekly were the most effective agents for weight and fat loss, and among the least effective for preserving lean mass. Liraglutide, a once-daily agent studied at 1.8 and 3.0 mg, was the only one that achieved significant weight reduction without a significant reduction in lean mass [1].

That is a genuine trade-off, and it is worth raising with whoever prescribes for you. It is not my place to say which drug belongs in your body. It is very much worth you knowing that the choice carries a body composition consequence, so that you can ask about it.

What actually protects muscle during treatment?

Here the research is encouraging and unusually clear.

Supervised resistance training programs running longer than ten weeks have produced increases of roughly three kilograms in lean mass and about twenty-five percent in strength, in both men and women [2]. Those numbers sit in the same range as what the drugs take away.

The authors of that review argue directly for tailored resistance exercise alongside these medications, to preserve lean mass while still achieving fat loss [2]. They add something worth holding onto: retaining lean mass during treatment may blunt the weight regain that tends to follow when the medication stops [2].

That last point deserves emphasis. Muscle is metabolically active tissue. Losing a quarter of your weight loss as muscle while the drug suppresses your appetite, then coming off it with less muscle than you started with, is the kind of thing the authors suggest could work against you if you regain weight afterward. Protecting muscle is not vanity. It is what gives the result a better chance of lasting.

Protein is the other half of it, and appetite suppression makes it genuinely harder to reach. That is exactly why it needs attention rather than assumption. If a drug has halved what you can comfortably eat, what you do eat has to work considerably harder.

What I am not telling you to do

I am not telling you to avoid these medications, and I am not telling you to stop one you are taking. Those decisions sit between you and your prescriber, they depend on your history and your risks, and nothing on this page can account for either.

What I am saying is narrower. If you are taking one of these drugs, or thinking about it, then lifting something heavy several times a week and paying deliberate attention to how much protein you are actually getting are not optional extras alongside the treatment. On the evidence, they are what decides whether you come out the other side lighter and strong, or simply smaller.

Ask your prescriber about lean mass. It is a fair question, the research supports asking it, and the answer changes what you should be doing while the medication works.

The Muscle You Keep is my book on exactly this question, written for women over 40. I take the wider GLP-1 picture apart in the next book in the series, Your Body's Own GLP-1; join the reader list and you will hear when it lands.

Sources

  1. Karakasis P, Patoulias D, Fragakis N, Mantzoros CS. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition- systematic review and network meta-analysis. Metabolism. 2025;164:156113. doi.org/10.1016/j.metabol.2024.156113
  2. Locatelli JC, Costa JG, Haynes A, et al. Incretin-based weight loss pharmacotherapy- can resistance exercise optimize changes in body composition? Diabetes Care. 2024;47(10):1718-1730. doi.org/10.2337/dci23-0100

← All posts

Free — no purchase needed

Get the Companion Workbook, free.

Join the reader list and I will send you the Companion Workbook and Quick-Start Checklist. Simple tools to turn what you are reading into daily practice, before you spend a penny on anything.

You'll get the workbook and checklist right away, then an occasional grounded note about root-cause health. No spam, no selling your address, and every email has a one-click unsubscribe.